Insider track record
OtherNot enough buy signals with a settled T+90 horizon to measure a track record yet.
Explore the complete record of transactions filed by Tabuteau Herriot. Insider active across 1 company, notably Axsome Therapeutics, Inc.. Cumulatively, 19 disclosures have been published. Breakdown: 0 buy · 7 sells. Total volume traded: €15.4m. History available since 12 September 2025. The latest transaction was filed on 5 August 2026 (Levée d'options). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Tabuteau Herriot
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations19 total
45,004 shares@ US$4.95Common StockSEC:0001193125-26-340688:0
45,004 shares@ US$212.01Common StockSEC:0001193125-26-340688:1
4,660 shares@ US$4.95Common StockSEC:0001193125-26-340688:2
4,660 shares@ US$213.95Common StockSEC:0001193125-26-340688:3
49,666 sharesCommon StockSEC:0001193125-26-292985:0
49,666 sharesCommon StockSEC:0001193125-26-292985:1
49,670 sharesCommon StockSEC:0001193125-26-264038:0
49,670 sharesCommon StockSEC:0001193125-26-264038:1
32,410 shares@ US$8.022.6% of flowCommon StockSEC:0001193125-26-033973:0
78,703 shares@ US$8.026.3% of flowCommon StockSEC:0001193125-26-006695:0
49,252 shares@ US$8.024.4% of flowCommon StockSEC:0001193125-25-308354:0
91,705 shares@ US$8.028.6% of flowCommon StockSEC:0001193125-25-267467:0
19,220 shares@ US$8.021.9% of flowCommon StockSEC:0001193125-25-234881:0
27,907 shares@ US$8.022.9% of flowCommon StockSEC:0001193125-25-205260:0
27,907 shares@ US$118.9642.4% of flowCommon StockSEC:0001193125-25-205260:1
15,254 shares@ US$8.021.6% of flowCommon StockSEC:0001193125-25-205260:2
15,254 shares@ US$117.3722.8% of flowCommon StockSEC:0001193125-25-205260:3
19,719 shares@ US$8.022.0% of flowCommon StockSEC:0001193125-25-205260:4
19,719 shares@ US$114.1928.4% of flowCommon StockSEC:0001193125-25-205260:5
About Tabuteau Herriot
TABUTEAU HERRIOT is Chief Executive Officer at Axsome Therapeutics, Inc. Across the 15 filings recorded, the 15 sampled filings between 2025-09-16 and 2026-07-01 show EUR 0 of buys and EUR 6247734 of sells, with Levée d'options as the most frequent transaction type.